HEALTH OF WOMAN. 2018.2(128):81–84

Romashchenko O. V. , Biloholovska V. V. , Melnykov S. M. , Khodzhava M. M. , Myronenko N. O. , Babych O. V.
State Institution «Institute of Urology of the National Academy of Medical Sciences of Ukraine»

The objective: to determine the frequency and spectrum of female sexual dysfunctions (FSD) in premenopause.
Materials and methods. Average age of the beginning of menopause in Ukraine is 48.3 years. A psychological, sexological and gynaecological examination of 37 women aged from 46 to 48 with regular menstrual cycle was carried out. Sexological examination included: interview method questionnaire; the first-order estrogenic zones sensitivity determination (vibro-testing); genitals vascular responses value (duplex Doppler scanning of clitoris vessels in XARIA TOSHIBA machine before and after video-erotic stimulation); levels determination of estradiol (E2), total and free testosterone, and sex hormone-binding globulin(SHBG) in dynamics.
Results. Dyspareunia (21.6%) developed in last 1–2 years against the background of lubrication disturbance and was accompanied by the reduction of libido (18.9%), formation of secondary anorgasmia (16.2%) and disharmony in relations of partners (18.9%). Doppler scanning of clitoris vessels registered hypokinemia rate at rest 1.7–2.5 cm/sec and in 30 minutes after video-erotic stimulation – 3.7–4.5 cm/sec. It did not change among the 16.2% of women with FSD (dyspareunia, reduction of sexual desire, anorgasmia) and was 0.9 to 1.4 cm/sec. Vibro test determination of marginal sensitivity of erogenous zones of first rank detected the increase in pain susceptibility of first order erogenous zones. The patients with sexual dysfunctions had reduced E2 concentration in blood (in 1.2–1.5 times) and free testosterone index reduction (in 1.3–1.5 times) in comparison to women with the preserved sexual health. Treatment of female sexual dysfunctions was based on the principles of interdisciplinary approach: both individual and couple psychotherapy, local use of suppositories with estriol and a course of plasmotherapy. The couple’s sexual harmony was achieved.
Conclusions. Dyspareunia is a primary sign of genitourinary disorders at the background of changes of hormonal homeostasis and requires timely adequate reaction. FSD prevention has to be conducted in premenopause, to be complex and to take into account the general state, age changes (namely it has to improve clitoral sensation and vaginal lubrication) of a woman and psychological problems of spouses in a single context.
Key words: female sexual dysfunctions, dyspareunia, urogenital disorders, premenopause.
REFERENCES

1. Romashchenko O, Melnikov S, Bilogolovska V, Mironenko N, Khodzhava M, Koval S. 2017. Formation of Dyspareunia in Women with Surgical Menopause. J Sex Med. Suppl. 3, 14;4:157–158.

2. Nappi RE, Lachowsky M. 2009. Menopause and sexuality: Prevalence of symptoms and impact on quality of life. Maturitas. 63:138–141. https://doi.org/10.1016/j.maturitas.2009.03.021. PMid:19464129

3. Balan VE. 1998. Urogenitalnyie rasstroystva v klimakterii. Akusherstvo i ginekologiya 6:12–15.

4. Tan O, Bradshaw K, Carr B. 2012. Management of vulvovaginal atrophy-related sexual dusfunction in postmenopausal womens: An up-to-date review. Menopause 19:109–117. https://doi.org/10.1097/gme.0b013e31821f92df; PMid:22011753

5. Doshani A, Pitchforth E. 2013. The value of qualitative research in urogynecology. BJOG 116:3–6. https://doi.org/10.1111/j.1471-0528.2008.01924.x; PMid:19016687

6. Herbenick B, Reece M, Schich V, Sanders SA. 2014. Women’s use and perceptions of commercial lubricants: Prevalence and characteristics in a nationally representative sample of American adults. J. Sex Med 11:642–652. https://doi.org/10.1111/jsm.12427; PMid:24521034

7. Tan O, Bradshaw K, Carr B. 2012. Management of vulvovaginal atrophy-related sexual dusfunction in postmenopausal womens: An up-to-date review. Menopause. 19:109–117. https://doi.org/10.1097/gme.0b013e31821f92df; PMid:22011753

8. Constantine GD et al. 2014. Incidence of genitourinary conditioning women with a diagnosis of vulvar vaginal/ atrophy. Curr Med Res Opin 30:143–148. https://doi.org/10.1185/03007995.2013.850068; PMid:24083677

9. Nappi R, Salonia A, Traish A. 2008. Clinical biologic pathophysiologies of women’s sexual dysfunction. J Sex Med. 2:4–25. https://doi.org/10.1111/j.1743-6109.2005.20102.x; PMid:16422901

10. Graham CA. 2009, Sep 26. The DSM diagnostic criterial for female orgasmic disorder. Arch Sex Behav. Epub ahead of print. doi: 10.1007/S10508- 009-9542-2.

11. Roos AM, Sultan AH, Thakar R. 2012. Sexual problems in the gynecology clinic: Are we making a mountain out of a molehill? Int Urogynecol J 23:145–152. https://doi.org/10.1007/s00192-011-1516-y; PMid:21796468

12. Romaschenko OV, Melnikov SN, Bilogolovskaya VV, Koval SB, Yaschenko LB. 2012. Seksualnoe zdorove, kak sostavlyayuschaya kachestva zhizni zhenschin elegantnogo vozrasta. Zdorove zhenschiny 9:76–82.

13. Roos AM, Sultan AH, Thakar R. 2012. Sexual problems in the gynecology clinic: Are we making a mountain out of a molehill? Int Urogynecol J. 23:145–152. https://doi.org/10.1007/s00192-011-1516-y; PMid:21796468

14. Sand M, Fisher WA. 2007. Women’s endorsement of models of female sexual response: The nurses’ sexuality study. J Sex Med 4:708–19. https://doi.org/10.1111/j.1743-6109.2007.00496.x; PMid:17498106

15. Min K, Choi S, Goldstein I. 2003. Effect of ovariectomy and estrogen replacement on basal and pelvic nerve stimulated vaginal lubrication in an animal model. J Marital and Sex Therapy 29 (Suppl 1): 77-84, 160. https://doi.org/10.1080/713847131; PMid:12735091

16. Buisson O, Foldes P, Paniel B-J. 2008. Sonography of the clitoris. J. Sex. Med. 5;2:413–417. https://doi.org/10.1111/j.1743-6109.2007.00699.x; PMid:18179463